VEOZAH Support Solutions is here to help your patients access VEOZAH. Click below or scroll down to discover:
Commercially insured patients may pay $0 for the first monthly prescription and may pay
as
little as $30
per monthly refill, regardless of income.b
Help your patients get started by sharing the link to the website where they can download the VEOZAH Savings Card. Tell them they can present the Savings Card at the pharmacy to receive savings if they are eligible.
To find out if your patient qualifies for other savings options:
Option 1
You can submit their prescription to VEOZAH Support Solutions via eRx. Select:
Sonexus Health Pharmacy Services:
2730 South Edmonds Lane, Ste 300
Lewisville, TX 75067
NPI Number: 1447680210
NCPDP: 5910206
VEOZAH Support Solutions will contact your patient to provide information about potential savings options that may be available to them. If eligible, VEOZAH will be shipped directly to the patient each month they are enrolled.
If you are having trouble sending the prescription to VEOZAH Support Solutions electronically, you can call in the prescription to 1-866-239-1637 or fax the prescription to 1-866-781-4998.
Option 2
You can share this link to the website where your patients can enroll in VEOZAH Support Solutions online.
The Astellas Patient Assistance ProgramC (PAP) provides VEOZAH at no cost to uninsured patients who meet the program eligibility requirements.
Share this link with your uninsured patients so
they can apply for the Astellas PAP online or
tell them to call
1-866-239-1637 to learn
more.
If your patient is approved for the Astellas PAP, VEOZAH will be shipped directly to them each month they are eligible.
Patients can call VEOZAH Support Solutions at 1-866-239-1637 to find out what other assistance options and/or information may be available to them.
Submit the prescription directly to the patient’s preferred pharmacy
Submit a completed prior authorization form to the patient’s insurance provider along with the prescription.
If your patient experiences an insurance-related delay, you can submit the prescription via eRx to Sonexus Health Pharmacy Services to initiate patient enrollment in VEOZAH Support Solutions.
Sonexus Health Pharmacy Services:
2730 South Edmonds Lane, Ste 300 Lewisville, TX 75067
NPI Number: 1447680210
NCPDP: 5910206
Patient Support Program Flashcard for HCPs
Overview of VEOZAH Support Solutions and the Patient Support
Programs that may be available for patients prescribed VEOZAH and
how they can get started.
Patient Tearsheet
Educational resource to help you inform your patients about
potential VEOZAH financial assistance options and how to apply.
Checklist for Requesting Prior Authorization or Formulary Exception
A list of frequently requested information for prior authorizations
and information that may be included for formulary exceptions.
Sample Letter of Medical Necessity
Customizable letter for requesting insurance coverage for VEOZAH.
Sample Letter of Denial Appeal
Customizable letter for appealing a denied prior authorization request.
Sample Letter of Formulary Exception
Customizable letter for requesting a formulary exception for VEOZAH.
Patient Authorization and Attestation Statement
Form to be filled out by the patient or caregiver that gives
permission for VEOZAH Support Solutions to work with the
healthcare provider and the patient’s health insurance plan.
Proper coding and billing can help facilitate timely claims processing and reduce the risk of denied claims. Coding requirements vary by payer.1 The ICD-10-CM diagnosis codes may assist you in coding for VEOZAH.d
Alphanumeric classification descriptive of diseases, injuries, and causes of death, used in hospital outpatient and physician office settings.
Code | Code Description |
N95.1 | Menopausal and female climacteric states |
R23.2 | Flushing (code first, if applicable, menopausal and female climacteric states [N95.1]) |
E89.40 | Asymptomatic postprocedural ovarian failure Postprocedural ovarian failure NOS |
E89.41 | Symptomatic postprocedural ovarian failure |
R61 | Generalized hyperhidrosis (code first, if applicable, menopausal and female climacteric states [N95.1]) |
Z78.0 |
Asymptomatic menopausal state Menopausal state NOS Postmenopausal status NOS |
REFERENCES
1. Beck DE, Margolin DA. Physician coding and reimbursement. Ochsner J 2007;7:8-15.
2. Centers for Disease Control and Prevention. ICD-10-CM tabular list of diseases and injuries (06-29-2023).
https://www.cms.gov/files/zip/2024-code-tables-tabular-and-index-updated-06/29/2023.zip.
Accessed 07-18-2023.
dIMPORTANT INFORMATION: The coding information contained herein is gathered from various resources, general in nature, and subject to change without notice. Third-party payment for medical products and services is affected by numerous factors. It is always the provider’s responsibility to determine the appropriate healthcare setting and to submit true and correct claims conforming to the requirements of the relevant payer for those products and services rendered. Pharmacies (or any other provider submitting a claim) should contact third-party payers for specific information on their coding, coverage, and payment policies. Information and materials provided by VEOZAH Support Solutions are to assist providers, but the responsibility to determine coverage, reimbursement, and appropriate coding for a particular patient remains at all times with the provider, and information provided by VEOZAH Support Solutions or Astellas should in no way be considered a guarantee of coverage or reimbursement for any product or service.
VEOZAH Support Solutions is here to help.
Please call if you have questions or need assistance. Translators are available.
1-866-239-1637, Monday–Friday, 8:00 AM–8:00 PM ET
By clicking “Continue,” you will leave this site and enter .
Terms & Conditions
By enrolling in the VEOZAH Savings Program (“Program”), the patient acknowledges that they currently meet the eligibility criteria and will comply with the following terms and conditions: The Program is for eligible patients with commercial prescription insurance and is good for use only with a valid prescription for VEOZAH® (fezolinetant) at the time the prescription is dispensed by the pharmacy. The Program has an annual maximum copay assistance limit of $4,000 per calendar year. After the annual maximum on copay assistance is reached, patient will be responsible for the remaining monthly out-of-pocket costs for VEOZAH. The Program is not valid for patients whose prescription claims are reimbursed, in whole or in part, by any state or federal government program, including, but not limited to, Medicaid, Medicare, Medigap, Department of Defense (DoD), Veterans Affairs (VA), TRICARE, Puerto Rico Government Insurance, or any state patient or pharmaceutical assistance program. Patients who move from commercial insurance to federal or state prescription health insurance will no longer be eligible, and agree to notify the Program of any such change. Patients agree not to seek reimbursement from any health insurance or third party for all or any part of the benefit received by the patient through the Program. This offer is not conditioned on any past, present, or future purchase of VEOZAH. This offer is not transferrable, has no cash value, and cannot be combined with any other offer, free trial, prescription savings card, or discount (including any program offered by a third party payer or pharmacy benefit manager, or an agent of either, that adjusts patient cost-sharing obligations, through arrangements that may be referred to as “accumulator” or “maximizer” programs). The full value of the Program benefits is intended to pass entirely to the eligible patient. No other individual or entity (including, without limitation, third party payers, pharmacy benefit managers, or the agents of either) is entitled to receive any benefit, discount or other amount in connection with this Program. This offer is not health insurance and is only valid for patients in the 50 United States, Washington DC, and Puerto Rico. This offer is not valid for cash paying patients. This Program is void where prohibited by law. No membership fees. It is illegal to sell, purchase, trade, counterfeit, duplicate, or reproduce, or offer to sell, purchase, trade, counterfeit, duplicate or reproduce the card. This offer will be accepted only at participating pharmacies. Certain rules and restrictions apply. Astellas reserves the right to revoke, rescind, or amend this offer without notice for any reason (including to ensure that the offer is utilized solely for the patient’s benefit).